Even before COVID-19 pushed access to an all-time low of roughly 20%, access has been declining for more than a decade. Post-pandemic, many think it remains lower.
Karl Goossens, director of commercial analytics at Veeva Systems Europe, recently spoke with pharmaphorum, discussing how effective omnichannel execution drives revenue and productivity.
If you already know your KOLs, at some point you will most likely want to perform a validation exercise to avoid the dangers of becoming over-familiar or over-confident in your list of Experts.
Japanese pharma group Eisai says it is battling a ransomware attack that was launched last weekend and has resulted in some of its servers becoming encrypted.
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas